img-1501669549334
Program at a Glance
Do not miss the Program at a Glance
img-1501669549334
Photo Gallery
Check out the INS Meeting Photo Gallery
img-1501669549334
CE Workshops
CE workshops are available now
img-1501669549334
Registration
Registration for INS Meeting is open now

Cognitive assessment in liver and kidney disease

Cognitive changes in liver and kidney disease can be subtle, fluctuating and easily mistaken for fatigue, depression or normal ageing. A patient may report slowed thinking, poor concentration, memory lapses or difficulty managing medicines, while a brief appointment captures only a relatively good moment.

Cognitive Impairment in Liver and Kidney Disease: Assessment Tips should therefore combine medical history, behavioural observation, targeted testing and information from family or carers. The aim is to distinguish a reversible delirium-like state from persistent neurocognitive difficulty and to identify practical risks in everyday life.

Start with the medical timeline

Clarify the onset and pattern of cognitive symptoms. Hepatic encephalopathy may fluctuate with infection, constipation, gastrointestinal bleeding, dehydration or medication changes. In advanced kidney disease, cognition can be affected by uraemia, anaemia, vascular disease, sleep disruption and the demands of dialysis.

Record recent admissions, transplantation status, dialysis schedule and laboratory abnormalities where available. A sudden decline requires medical review before interpreting test scores as evidence of a stable disorder.

Look beyond memory complaints

Patients often describe “memory problems” when the primary difficulty is slowed processing, inattention or executive dysfunction. Ask how they manage appointments, finances, cooking, driving, online banking and medication timing. Errors in these activities may be more informative than a single delayed-recall score.

Include collateral information from a partner, adult child or support worker. In Australia, dialysis commonly involves several visits each week, and transport, early appointments and post-treatment fatigue can temporarily reduce concentration without indicating a progressive condition.

Plan a culturally safe assessment

Language, education, migration history and familiarity with formal testing can influence performance. Use a qualified interpreter when needed rather than relying on relatives, and explain that the assessment is about brain function rather than intelligence or personal worth. Cultural safety is especially important when working with Aboriginal and Torres Strait Islander people, including those travelling from remote communities to regional or metropolitan hospitals.

Select measures with suitable normative data and interpret results in context. Resources on cultural adaptations can help clinicians think carefully about translated instructions, educational opportunity and culturally shaped test familiarity.

Build a focused test battery

Begin with orientation, alertness, working memory, processing speed, verbal fluency and learning. Add visuospatial and executive measures when the referral question involves driving, work, independent living or treatment adherence. A short bedside screen can identify concern, but it should not replace a broader assessment when decisions carry significant consequences.

Repeat assessment may be useful after metabolic stabilisation or treatment of encephalopathy. Document the patient’s sleep, pain, dialysis timing, recent lactulose use, sedating medicines and hearing or vision status on the test day.

Interpret patterns rather than totals

A low overall score may reflect acute illness, limited English proficiency, low literacy, sensory impairment or fatigue. Examine the pattern of errors: inconsistent attention suggests fluctuation, while inefficient learning with improved recognition may point to retrieval difficulty rather than rapid forgetting.

Compare results with previous functioning and, where possible, earlier scores. Avoid treating a small score difference as meaningful without considering practice effects, reliable-change methods and the conditions under which each assessment occurred.

Use a practical assessment checklist

Before testing, record the following:

  • Current medical stability and recent encephalopathy episodes
  • Dialysis timing, sleep quality and treatment-related fatigue
  • Medicines with anticholinergic, sedating or psychoactive effects
  • Preferred language, interpreter needs and educational background

During feedback, check these functional domains:

  • Medication organisation and appointment attendance
  • Cooking, shopping, finances and digital banking
  • Driving, workplace safety and falls risk
  • Carer capacity, consent and available community support

A written summary should separate observed cognitive findings from assumptions about capacity. Explain which abilities are intact, what support is required and what should trigger urgent medical review.

Connect findings with Australian care

Recommendations should fit the person’s actual health service and finances. A private neuropsychological assessment may involve out-of-pocket costs because Medicare coverage does not necessarily meet the full fee. Public hospital teams, renal services, general practitioners and Aboriginal Community Controlled Health Services may provide more practical referral pathways.

If cognitive difficulties affect daily function, document them in language relevant to disability and support applications. Evidence for the National Disability Insurance Scheme must describe functional impact rather than simply naming a diagnosis, while privacy and information-sharing should follow applicable Australian health-record and consent requirements.

Clear communication can prevent avoidable harm. Coordinate with hepatology, nephrology, pharmacy, occupational therapy and family supports, and provide concrete strategies such as written routines, blister packs, appointment reminders and simplified instructions. Professional resources and conference materials, including the INS 2018 meeting site, offer useful context for linking neuropsychological science with humane clinical care.

The INS 2018 is over...

General Information

Important information about the meeting

Industry

Support and exhibition opportunities

Czech Republic

Beautiful country situated in the very heart of Europe

Contact

How can we help you?
Meeting Venue
img-1501676046170
Prague Congress Centre (KCP)
5.května 65
140 21 Prague 4
Czech Republic
Phone: +420 261 171 111
Website: www.kcp.cz
Copyright © 2017 - GUARANT International spol. s r.o. All rights reserved. Powered by APPTIDE.